Helium One plc (LON:HE1) Chief Executive Officer David Minchin and Drilling Superintendent Mike Williams caught up with DirectorsTalk for an exclusive interview to discuss how the rig is progressing, the..
iEnergizer (LON:IBPO), the technology services and media solutions leader for the digital age, recently reported its annual results for the year ended March 31, 2022. The company said it achieved..
Fidelity Asian Values plc (LON:FAS) performance is driven by stock selection, and that should never be overlooked. However, being in appealing markets gives favourable tailwinds, and, in this note, we..
AstraZeneca plc (LON:AZN) has announced an agreement to acquire TeneoTwo, Inc.i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluation in relapsed and refractory B-cell non-Hodgkin lymphoma1...
B&M European Value Retail S.A. (LON:BME), the UK’s leading variety goods value retailer, has announced that Mike Schmidt is to be appointed as an Executive Director and Chief Financial Officer..
J Sainsbury plc (LON:SBRY) has announced its first quarter trading statement for the 16 weeks to 25 June 2022. Financial highlights and outlook · Good grocery performance, with sales..
SmartSpace Software Plc, (LON:SMRT) the leading provider of ‘Integrated Space Management Software’ for smart buildings and commercial spaces – ‘visitor reception, desks and meeting rooms’, will be holding its Annual..
Cizzle Biotechnology plc (LON:CIZ), the UK based diagnostics developer, has today provided an update on the Company’s progress to develop antibodies for use in its proprietary early lung cancer tests,..
Edenville Energy Plc (LON:EDL), the operator of the Rukwa Coal Project in Tanzania, has announced a restructuring of its Board as the Company looks to expand its Rukwa project to..
Caledonia Mining Corporation Plc (LON:CMCL) has announced that the Board of Directors has declared a quarterly dividend of 14 United States cents (US$0.14) on each of the Company’s shares. Highlights..
Nuformix plc (LON:NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, has announced that both of the abstracts submitted for presentation at the..
